MBX.TO लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (1 May 2024 @ 20:12):

Stats
आज की मात्रा	1 500.00
औसत मात्रा	76 504.00
बाजार मूल्य	46.43M
EPS	$0 ( 2024-02-14 )
अगली कमाई की तारीख	( $0 ) 2024-05-08
Last Dividend	$0.275 ( 1999-09-02 )
Next Dividend	$0 ( N/A )
P/E	11.33
ATR14	$0 (0.00%)

Microbix Biosystems Inc सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध

10 सबसे अधिक नकारात्मक सहसंबंध

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

Microbix Biosystems Inc वित्तीय

Annual	2023
राजस्व:	$16.51M
सकल लाभ:	$7.48M (45.30 %)
EPS:	$-0.000300

FY	2023
राजस्व:	$16.51M
सकल लाभ:	$7.48M (45.30 %)
EPS:	$-0.000300

FY	2022
राजस्व:	$19.08M
सकल लाभ:	$11.12M (58.32 %)
EPS:	$0.0132

FY	2021
राजस्व:	$18.59M
सकल लाभ:	$11.04M (59.40 %)
EPS:	$0.0280

Financial Reports:

No articles found.

Microbix Biosystems Inc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Microbix Biosystems Inc Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 3.34 - No dividend growth expected in the near future

Information

First Dividend	$0.275	1999-09-02
Last Dividend	$0.275	1999-09-02
Next Dividend	$0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	$0.275	--
Avg. Dividend % Per Year	0.00%	--
Score	2.33	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	3.34
Div. Directional Score	7.72	--

Next Divdend (Est)
(2024-05-02)

$0 Estimate 0.00 %

Dividend Stability

0.00 Very Bad

Dividend Score

2.33

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield
1999	$0	0.00%
2000	$0	0.00%
2001	$0	0.00%
2002	$0	0.00%
2003	$0	0.00%
2004	$0	0.00%
2005	$0	0.00%
2006	$0	0.00%
2007	$0	0.00%
2008	$0	0.00%
2009	$0	0.00%
2010	$0	0.00%
2011	$0	0.00%
2012	$0	0.00%
2013	$0	0.00%
2014	$0	0.00%
2015	$0	0.00%
2016	$0	0.00%
2017	$0	0.00%
2018	$0	0.00%
2019	$0	0.00%
2020	$0	0.00%
2021	$0	0.00%
2022	$0	0.00%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for TSX

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
ZESG.TO	Dividend Junior	2023-06-28	Quarterly	5	1.17%
STLC.TO	Dividend King	2023-08-17	Quarterly	7	3.37%
HUBL.TO	Dividend Knight	2023-08-30	Monthly	7	3.76%
CBH.TO	Dividend King	2023-09-25	Monthly	13	1.79%
XDUH.TO	Dividend Knight	2023-08-25	Monthly	7	1.47%
PLC.TO	Dividend Knight	2023-06-29	Bi-Monthly	14	0.77%
EXE.TO	Dividend King	2023-09-28	Monthly	13	4.13%
ZRE.TO	Dividend Knight	2023-08-29	Monthly	15	2.60%
TLF.TO	Dividend King	2023-08-30	Monthly	13	3.15%
L-PB.TO	Dividend King	2023-09-14	Quarterly	10	3.24%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.157	1.500	6.87	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0957	1.200	6.81	8.17	[0 - 0.3]
returnOnEquityTTM	0.144	1.500	9.52	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	8.53	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	5.99	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	4.60	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0.164	-1.500	7.27	-10.00	[0 - 0.6]
interestCoverageTTM	5.12	1.000	9.21	9.21	[3 - 30]
operatingCashFlowPerShareTTM	0.00702	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.000274	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0.221	-1.500	9.12	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.558	1.000	4.03	4.03	[0.2 - 0.8]
operatingProfitMarginTTM	0.200	1.000	8.01	8.01	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.159	1.000	-0.226	-0.226	[0.2 - 2]
assetTurnoverTTM	0.611	0.800	9.26	7.41	[0.5 - 2]
Total Score				12.10

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	13.22	1.000	8.77	0	[1 - 100]
returnOnEquityTTM	0.144	2.50	9.69	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.000274	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.00702	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.107	1.500	-2.62	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0427	1.000	-1.431	0	[0.1 - 0.5]
Total Score				3.34

Microbix Biosystems Inc

Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. It manufactures a range of critical biological materials for the diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment and proficiency (QAPs) that support clinical lab proficiency testing, assay development and validation, or clinical lab workflows. The company also applies its biological expertise and infrastructure to develop other proprietary products, primarily viral transport medium (DxTM) to stabilize patient samples for lab-based testing and Kinlytic Urokinase, a biologic thrombolytic drug used to treat blood clots. It sells QAPs to lab accreditation organizations, diagnostics companies, and clinical labs through a network of regional distributors. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.